Immunizations in chronic liver disease: what should be done and what is the evidence (Q38068355)

28 August 2017

1 reference

title

Immunizations in chronic liver disease: what should be done and what is the evidence (English)

1 reference

28 August 2017

0 references

1 reference

chronic liver disease

0 references

author name string

Michael D Leise

series ordinal

1

1 reference

PubMed ID

23250700

28 August 2017

Jayant A Talwalkar

series ordinal

2

1 reference

28 August 2017

1 January 2013

1 reference

Current gastroenterology reports

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

1

1 reference

28 August 2017

300

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-012-0300-6

28 August 2017

0 references

cites work

Hepatic decompensation in patients with cirrhosis during infection with influenza A.

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Clinical impact of influenza immunization in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Influenza vaccination in patients with cirrhosis and in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Pneumococcal vaccine response in cirrhosis and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Immunogenicity of hepatitis A vaccine in decompensated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0300-6

Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?

21 January 2018

1 reference

12 December 2020

Response to hepatitis B vaccination by liver transplant candidates

1 reference

12 December 2020

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

1 reference

12 December 2020

The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C

1 reference

12 December 2020

Hepatitis B vaccination. Response of alcoholic with and without liver injury

1 reference

12 December 2020

Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme

1 reference

12 December 2020

Immune response to influenza vaccine in adult liver transplant recipients

1 reference

12 December 2020

Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients

1 reference

12 December 2020

Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Seroprevalence of hepatitis A immunity among brazilian adult patients with liver cirrhosis: is HAV vaccination necessary?

1 reference

12 December 2020

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States

1 reference

12 December 2020

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

1 reference

12 December 2020

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

12 December 2020

Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list

1 reference

12 December 2020

Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial

1 reference

12 December 2020

Efficacy of influenza vaccination in adult liver transplant recipients

1 reference

12 December 2020

Efficacy of a reinforced protocol of HBV vaccination in cirrhotic patients waiting for orthotopic liver transplantation

1 reference

12 December 2020

Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population

1 reference

12 December 2020

Mortality of dialysis patients according to influenza and pneumococcal vaccination status

1 reference

12 December 2020

Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital

1 reference

12 December 2020

Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates

1 reference

12 December 2020

Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation?

1 reference

12 December 2020

Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.

1 reference

12 December 2020

10.1007/S11894-012-0300-6

Identifiers

DOI

1 reference

PubMed ID

23250700

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23250700